TFIGlobal
TFIGlobal
TFIPOST English
TFIPOST हिन्दी
No Result
View All Result
  • Indo-Pacific
  • Americas
  • Canada
  • Indian Subcontinent
  • West Asia
  • Europe
  • Africa
  • The Caribbean
TFIGlobal
  • Indo-Pacific
  • Americas
  • Canada
  • Indian Subcontinent
  • West Asia
  • Europe
  • Africa
  • The Caribbean
No Result
View All Result
TFIGlobal
TFIGlobal
No Result
View All Result
  • Indo-Pacific
  • Americas
  • Canada
  • Indian Subcontinent
  • West Asia
  • Europe
  • Africa
  • The Caribbean

Director and Chairman of Chinese Vaccine firm Sinopharm resign as China begins vaccinating its citizens

Sohil Sinha by Sohil Sinha
January 17, 2021
in Indian Subcontinent
Sinopharm, vaccine, Chinese
Share on FacebookShare on X

Sinopharm, a leading, albeit lagging in efficacy numbers, Chinese vaccine giant announced that its Chairman and a director have resigned on Tuesday citing personal reasons. After the vaccine was approved in China, Tao Lina, a famous Chinese vaccine expert described it as the world’s worst vaccine.

According to a filing by the Hong Kong-listed firm, the company cited personal reasons for Li Zhiming’s resignation. Li Hui, a director and audit committee member of the China National Medicines Corp. subsidiary of Sinopharm, also resigned on Tuesday for personal reasons, a separate filing disclosed.

Also Read

How US vs Russia, China clash is damaging global cybersecurity?

Putin’s show of strength, as global leaders gather for Victory Day Parade

China Loosens Monetary Policy to Brace for New Trade War Front

The Chinese authorities approved a vaccine produced for general launch by a Sinopharm subsidiary in Beijing in late December. According to state media, the company said the vaccine had an effectiveness of 79.34 per cent after a phase three test.

Despite having one of the worst efficacy rates, The Chinese state media and the Chinese government are still pushing the Sinopharm vaccine on their citizens.

Dr Tao Lina had claimed that the vaccine has 73 side effects, Lina had said on the Chinese social media platform Weibo that the COVID-19 vaccine developed by Sinopharm, which is a Chinese state-run company, is extremely unsafe for use, later his posts were retracted from the Chinese state-run platform.

There are a few side effects of each vaccine but 73 negative effects are well beyond their limits. Tao also says that this is ‘absolutely unprecedented’ in the number of adverse reactions. He also mocked the user’s manual as a ‘long disclaimer.’

Read More:‘What happens in Rio doesn’t stay in Rio,’ Brazil is exposing the Chinese vaccine like a legend

Despite the criticism from one of its own vaccine experts, China is continuing with the push of the Sinopharm vaccine. Chinese state media reported on Friday, “COVID-19 vaccine developed by China National Biotec Group (CNBG), a Sinopharm subsidiary, is safe in those aged between three and 17, based on clinical data obtained by the company.”

According to Xinhua News Agency, CNBG Chairman Yang Xiaoming, without providing further details said, “It should be noted that for three to five-year-old children because their immune system is still developing, they must be carefully and closely monitored during vaccination.”

The vaccine being developed by CNBG’s Beijing unit was the first in China to be approved for general public use in late December.

Even more alarming, is the bulletin issued by the Chinese government that if any person is harmed due to the side effects of the vaccines, then the Chinese manufacturer is not liable to suffer any losses.

Read More: China’s well-known vaccine expert declares Chinese vaccine as the worst in the world

A survey conducted in November earlier revealed that about 90 per cent of China’s frontline workers are not enthusiastic about the Chinese vaccine. According to this survey, only 10 per cent of workers at a local hospital in Shanghai expressed a desire to be vaccinated with a Chinese Vaccine for COVID-19. The remaining 90 per cent rejected any Chinese Vaccine due to a lack of confidence in the inefficient and scammed vaccine industry.

The efficacy rate of the Sinopharm vaccine is not up to global standards and despite this ‘known drawback,’ the Chinese government is aggressively pushing the vaccine on its own citizens and abroad. This could lead to a massive pharmaceutical disaster and this could also be the reason why Li Zhiming and Sinopharm’s Li Hui a director and audit committee member of Sinopharm subsidiary China National Medicines Corp. resigned.

Tags: ChinaShort takesSinopharmVaccine
ShareTweetSend
Sohil Sinha

Sohil Sinha

Also Read

India Exposes Western Media Bias & Global Arms Market Anxiety

India Exposes Western Media lies & Global Arms Market Anxiety

May 12, 2025
Pakistan's Loan Plea Crisis: Hacked Account or Desperate Plea for Financial Aid?

Pakistan’s international loan appeal: Hacked Account or begging?

May 9, 2025
India’s S-400 System Downs Pakistani F-16 and JF-17 Jets

India’s S-400 shoot down Pakistani F-16 Fighter jet

May 8, 2025
China's Proxy War in South Asia: Arming Pakistan and Spreading Disinformation"

China’s Proxy War: Arming Pakistan and Misinformation Tactics

May 8, 2025
Operation Sindoor: India’s Redline in the Rewritten World Order

 Operation Sindoor: India’s Redline in the Rewritten World Order

May 7, 2025
India on the charge: PM Modi cancels 65 year old treaty, throws out Pakistanis, seals borders

India on the charge: PM Modi cancels 65 year old treaty, throws out Pakistanis, seals borders

April 24, 2025
Youtube Twitter Facebook
TFIGlobalTFIGlobal
Right Arm. Round the World. FAST.
  • About Us
  • Contact Us
  • TFIPOST – English
  • TFIPOST हिन्दी
  • Careers
  • Brand Partnerships
  • Terms of use
  • Privacy Policy

©2025 - TFI MEDIA PRIVATE LIMITED

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Indo-Pacific
  • Americas
  • Canada
  • Indian Subcontinent
  • West Asia
  • Europe
  • Africa
  • The Caribbean
TFIPOST English
TFIPOST हिन्दी

©2025 - TFI MEDIA PRIVATE LIMITED

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. View our Privacy and Cookie Policy.